ID: ALA3344388

Max Phase: Preclinical

Molecular Formula: C21H24Cl2N2O2

Molecular Weight: 407.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N[C@@H](CC(=O)N1C[C@@H](CO)[C@H](c2ccc(Cl)cc2)C1)Cc1ccc(Cl)cc1

Standard InChI:  InChI=1S/C21H24Cl2N2O2/c22-17-5-1-14(2-6-17)9-19(24)10-21(27)25-11-16(13-26)20(12-25)15-3-7-18(23)8-4-15/h1-8,16,19-20,26H,9-13,24H2/t16-,19+,20-/m0/s1

Standard InChI Key:  ZFSKJGRASNTEBX-DBVUQKKJSA-N

Associated Targets(Human)

Peptide N-myristoyltransferase 1 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Leishmania donovani 89745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 407.34Molecular Weight (Monoisotopic): 406.1215AlogP: 3.49#Rotatable Bonds: 6
Polar Surface Area: 66.56Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.93CX LogP: 2.89CX LogD: 1.35
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.77Np Likeness Score: -0.10

References

1. Hutton JA, Goncalves V, Brannigan JA, Paape D, Wright MH, Waugh TM, Roberts SM, Bell AS, Wilkinson AJ, Smith DF, Leatherbarrow RJ, Tate EW..  (2014)  Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors.,  57  (20): [PMID:25238611] [10.1021/jm5011397]

Source